Search

Author/Creator Zelterman, Daniel

22. Tumor regression mediated by oncogene withdrawal or erlotinib stimulates infiltration of inflammatory immune cells in EGFR mutant lung tumors. Issue 1 (10th July 2019)

Authors:
Ayeni, Deborah; Miller, Braden; Kuhlmann, Alexandra; Ho, Ping-Chih; Robles-Oteiza, Camila; Gaefele, Mmaserame; Levy, Stellar; de Miguel, Fernando J.; Perry, Curtis; Guan, Tianxia; Krystal, Gerald; Lockwood, William; Zelterman, Daniel; Homer, Robert; Liu, Zongzhi; Kaech, Susan; Politi, Katerina
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

24. Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States. Issue 2 (22nd November 2016)

Authors:
Pine, Alexander B.; Lee, Eun‐Ju; Sekeres, Mikkael; Steensma, David P.; Zelterman, Daniel; Prebet, Thomas; DeZern, Amy; Komrokji, Rami; Litzow, Mark; Luger, Selina; Stone, Richard; Erba, Harry P.; Garcia‐Manero, Guillermo; Lee, Alfred I.; Podoltsev, Nikolai A.; Barbarotta, Lisa; Kasberg, Stephanie...
Journal:
Transfusion
Issue:
Volume 57:Issue 2(2017)
Page Start:
289
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗